Cargando…

Visual reading for [(18)F]Florzolotau ([(18)F]APN-1607) tau PET imaging in clinical assessment of Alzheimer’s disease

INTRODUCTION: Tau-targeted positron emission tomography (tau-PET) is a potential tool for the differential diagnosis of Alzheimer’s disease (AD) and to clarify the distribution of tau deposition. In addition to the quantitative analysis of tau-PET scans, visual reading supports the assessment of tau...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Huan-Chun, Lin, Kun-Ju, Huang, Kuo-Lun, Chen, Shih-Hsin, Ho, Tsung-Ying, Huang, Chin-Chang, Hsu, Jung-Lung, Chang, Chiung-Chih, Hsiao, Ing-Tsung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10213356/ https://www.ncbi.nlm.nih.gov/pubmed/37250400 http://dx.doi.org/10.3389/fnins.2023.1148054

Ejemplares similares

Characterization of (18)F-PM-PBB3 ((18)F-APN-1607) Uptake in the rTg4510 Mouse Model of Tauopathy
por: Weng, Chi-Chang, et al.
Publicado: (2020)

Associations of [(18)F]-APN-1607 Tau PET Binding in the Brain of Alzheimer’s Disease Patients With Cognition and Glucose Metabolism
por: Lu, Jiaying, et al.
Publicado: (2020)

(18)F-APN-1607 Tau Positron Emission Tomography Imaging for Evaluating Disease Progression in Alzheimer’s Disease
por: Xu, Xiaojun, et al.
Publicado: (2022)

Parametric Estimation of Reference Signal Intensity for Semi-Quantification of Tau Deposition: A Flortaucipir and [(18)F]-APN-1607 Study
por: Zhang, Huiwei, et al.
Publicado: (2021)

Radiation dosimetry and pharmacokinetics of the tau PET tracer florzolotau (18F) in healthy Japanese subjects
por: Miyamoto, Masaomi, et al.
Publicado: (2023)

(18)F-Florzolotau PET imaging captures the distribution patterns and regional vulnerability of tau pathology in progressive supranuclear palsy
por: Liu, Feng-Tao, et al.
Publicado: (2023)

In Vivo Tau Burden Is Associated with Abnormal Brain Functional Connectivity in Alzheimer’s Disease: A (18)F-Florzolotau Study
por: Ju, Zizhao, et al.
Publicado: (2022)

A Novel Individual Metabolic Brain Network for 18F-FDG PET Imaging
por: Huang, Sheng-Yao, et al.
Publicado: (2020)

Cryo-EM structures of tau filaments from Alzheimer’s disease with PET ligand APN-1607
por: Shi, Yang, et al.
Publicado: (2021)

Correction to: Cryo-EM structures of tau filaments from Alzheimer’s disease with PET ligand APN-1607
por: Shi, Yang, et al.
Publicado: (2021)

Tau PET With (18)F-THK-5351 Taiwan Patients With Familial Alzheimer's Disease With the APP p.D678H Mutation
por: Huang, Chin-Chang, et al.
Publicado: (2019)

Quantitative study of (18)F-(+)DTBZ image: comparison of PET template-based and MRI based image analysis
por: Jung Lung, Hsu, et al.
Publicado: (2018)

Uncovering distinct progression patterns of tau deposition in progressive supranuclear palsy using [(18)F]Florzolotau PET imaging and subtype/stage inference algorithm
por: Hong, Jimin, et al.
Publicado: (2023)

Misery Perfusion and Tau Deposition in Atherosclerotic Major Cerebral Artery Disease: A (18)F-Florzolotau Positron Emission Tomography Study
por: Yamauchi, Hiroshi, et al.
Publicado: (2022)

Improved interpretation of (18)F-florzolotau PET in progressive supranuclear palsy using a normalization-free deep-learning classifier
por: Lu, Jiaying, et al.
Publicado: (2023)

(18)F-THK5351 PET imaging in patients with progressive supranuclear palsy: associations with core domains and diagnostic certainty
por: Hsu, Jung-Lung, et al.
Publicado: (2020)

Author Correction: (18)F-THK5351 PET imaging in patients with progressive supranuclear palsy: associations with core domains and diagnostic certainty
por: Hsu, Jung-Lung, et al.
Publicado: (2021)

Visualization of ischemic stroke-related changes on (18)F-THK-5351 positron emission tomography
por: Huang, Kuo-Lun, et al.
Publicado: (2018)

Comparison of New Tau PET-Tracer Candidates With [(18)F]T808 and [(18)F]T807
por: Declercq, Lieven, et al.
Publicado: (2016)

Plasma Aβ analysis using magnetically-labeled immunoassays and PET (18)F-florbetapir binding in non-demented patients with major depressive disorder
por: Wu, Kuan-Yi, et al.
Publicado: (2018)

Brain Imaging of Vesicular Monoamine Transporter Type 2 in Healthy Aging Subjects by (18)F-FP-(+)-DTBZ PET
por: Lin, Kun-Ju, et al.
Publicado: (2013)

Author Correction: Plasma Aβ analysis using magnetically-labeled immunoassays and PET (18)F-florbetapir binding in non-demented patients with major depressive disorder
por: Wu, Kuan-Yi, et al.
Publicado: (2019)

Comparison of (18)F-T807 and (18)F-THK5117 PET in a Mouse Model of Tau Pathology
por: Brendel, Matthias, et al.
Publicado: (2018)

Development, initial validation, and application of a visual read method for [(18)F]MK‐6240 tau PET
por: Shuping, Joanna L., et al.
Publicado: (2023)

GMP-compliant fully automated radiosynthesis of [(18)F]FEPPA for PET/MRI imaging of regional brain TSPO expression
por: Chang, Chi-Wei, et al.
Publicado: (2021)

Integrated (18)F-T807 Tau PET, Structural MRI, and Plasma Tau in Tauopathy Neurodegenerative Disorders
por: Li, Cheng-Hsuan, et al.
Publicado: (2021)

Quantification of Tau Load Using [(18)F]AV1451 PET
por: Golla, Sandeep S. V., et al.
Publicado: (2017)

An updated radiosynthesis of [(18)F]AV1451 for tau PET imaging
por: Mossine, Andrew V., et al.
Publicado: (2017)

(18)F-MK-6240 tau-PET in genetic frontotemporal dementia
por: Levy, Jake P, et al.
Publicado: (2021)

Comparison of (18)F-FDG, (18)F-Fluoroacetate, and (18)F-FEPPA for Imaging Liver Fibrosis in a Bile Duct-Ligated Rat Model
por: Wu, Chun-Yi, et al.
Publicado: (2021)

Assessment of perfusion deficit with early phases of [(18)F]PI-2620 tau-PET versus [(18)F]flutemetamol-amyloid-PET recordings
por: Völter, Friederike, et al.
Publicado: (2022)

Added Value of Using a Cocktail of F-18 Sodium Fluoride and F-18 Fluorodeoxyglucose in Positron Emission Tomography/Computed Tomography for Detecting Bony Metastasis: A Case Report
por: Chan, Hung-Pin, et al.
Publicado: (2015)

Regional Amyloid Deposition in Amnestic Mild Cognitive Impairment and Alzheimer's Disease Evaluated by [(18)F]AV-45 Positron Emission Tomography in Chinese Population
por: Huang, Kuo-Lun, et al.
Publicado: (2013)

A multicenter comparison of [(18)F]flortaucipir, [(18)F]RO948, and [(18)F]MK6240 tau PET tracers to detect a common target ROI for differential diagnosis
por: Leuzy, Antoine, et al.
Publicado: (2021)

Detection of tau in Gerstmann-Sträussler-Scheinker disease (PRNP F198S) by [(18)F]Flortaucipir PET
por: Risacher, Shannon L., et al.
Publicado: (2018)

(18)F-flortaucipir (AV-1451) tau PET in frontotemporal dementia syndromes
por: Tsai, Richard M., et al.
Publicado: (2019)

Evaluation of a visual interpretation method for tau‐PET with (18)F‐flortaucipir
por: Sonni, Ida, et al.
Publicado: (2020)

Early-phase (18)F-FP-CIT and (18)F-flutemetamol PET were significantly correlated
por: An, Young-Sil, et al.
Publicado: (2021)

Assessment of Tau Pathology as Measured by (18)F-THK5317 and (18)F-Flortaucipir PET and Their Relation to Brain Atrophy and Cognition in Alzheimer’s Disease
por: Colato, Elisa, et al.
Publicado: (2021)

Prognostic Value of Baseline Radiomic Features of (18)F-FDG PET in Patients with Diffuse Large B-Cell Lymphoma
por: Lue, Kun-Han, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9nbmlb7h604rdqdkose7csfe0k